抗血管内皮生长因子在早产儿视网膜病变治疗中的作用

US ophthalmic review Pub Date : 2017-01-01 DOI:10.17925/USOR.2017.10.01.57

Christopher D Conrady, M. Hartnett

{"title":"抗血管内皮生长因子在早产儿视网膜病变治疗中的作用","authors":"Christopher D Conrady, M. Hartnett","doi":"10.17925/USOR.2017.10.01.57","DOIUrl":null,"url":null,"abstract":"Acknowledgements: This work was supported in part by an unrestricted grant from Research to Prevent Blindness to the University of Utah’s Department of Ophthalmology and Visual Sciences and National Eye Institute R01 grants EY015130 and EY017011 to MEH. M. Elizabeth Hartnett has received NIH grant support as principal investigator for the following: R01EY015130, R01EY017011, T35EY026511. The authors would also like to thank Lane Bennion for the medical renderings.","PeriodicalId":90077,"journal":{"name":"US ophthalmic review","volume":"10 1","pages":"57"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":"{\"title\":\"The Role of Anti-vascular Endothelial Growth Factor Agents in the Management of Retinopathy of Prematurity\",\"authors\":\"Christopher D Conrady, M. Hartnett\",\"doi\":\"10.17925/USOR.2017.10.01.57\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Acknowledgements: This work was supported in part by an unrestricted grant from Research to Prevent Blindness to the University of Utah’s Department of Ophthalmology and Visual Sciences and National Eye Institute R01 grants EY015130 and EY017011 to MEH. M. Elizabeth Hartnett has received NIH grant support as principal investigator for the following: R01EY015130, R01EY017011, T35EY026511. The authors would also like to thank Lane Bennion for the medical renderings.\",\"PeriodicalId\":90077,\"journal\":{\"name\":\"US ophthalmic review\",\"volume\":\"10 1\",\"pages\":\"57\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"US ophthalmic review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17925/USOR.2017.10.01.57\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"US ophthalmic review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17925/USOR.2017.10.01.57","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 6

摘要

致谢:这项工作部分得到了美国犹他大学眼科学与视觉科学系预防失明研究中心和美国国家眼科研究所R01基金EY015130和EY017011对MEH的无限制资助。M. Elizabeth Hartnett已获得NIH拨款支持，担任以下项目的首席研究员:R01EY015130, R01EY017011, T35EY026511。作者还想感谢Lane Bennion提供的医学渲染图。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The Role of Anti-vascular Endothelial Growth Factor Agents in the Management of Retinopathy of Prematurity

Acknowledgements: This work was supported in part by an unrestricted grant from Research to Prevent Blindness to the University of Utah’s Department of Ophthalmology and Visual Sciences and National Eye Institute R01 grants EY015130 and EY017011 to MEH. M. Elizabeth Hartnett has received NIH grant support as principal investigator for the following: R01EY015130, R01EY017011, T35EY026511. The authors would also like to thank Lane Bennion for the medical renderings.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

US ophthalmic review

自引率

0.00%

发文量